Steward Partners Investment Advisory’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.15K Sell
513
-1,900
-79% -$15.8K ﹤0.01% 3895
2026
Q1
$20.2K Buy
2,413
+1,750
+264% +$18.4K ﹤0.01% 3223
2025
Q4
$9.55K Sell
663
-12,500
-95% -$156K ﹤0.01% 3462
2025
Q3
$127K Buy
13,163
+7,500
+132% +$66.3K ﹤0.01% 2096
2025
Q2
$46.5K Buy
5,663
+5,000
+754% +$41.9K ﹤0.01% 2519
2025
Q1
$4.74K Buy
663
+400
+152% +$2.98K ﹤0.01% 3397
2024
Q4
$2.03K Sell
263
-26,100
-99% -$245K ﹤0.01% 3628
2024
Q3
$277K Sell
26,363
-1,500
-5% -$18.3K ﹤0.01% 1366
2024
Q2
$326K Buy
27,863
+19,600
+237% +$305K ﹤0.01% 1244
2024
Q1
$174K Buy
8,263
+8,000
+3,042% +$142K ﹤0.01% 1505
2023
Q4
$4.72K Sell
263
-50
-16% -$881 ﹤0.01% 2980
2023
Q3
$5.15K Buy
313
+113
+57% +$2.05K ﹤0.01% 2810
2023
Q2
$4K Hold
200
﹤0.01% 2862
2023
Q1
$3.78K Hold
200
﹤0.01% 2869
2022
Q4
$4.54K Sell
200
-120
-38% -$2.71K ﹤0.01% 2806
2022
Q3
$8K Hold
320
﹤0.01% 2622
2022
Q2
$8K Hold
320
﹤0.01% 2605
2022
Q1
$11K Buy
320
+100
+45% +$2.78K ﹤0.01% 2631
2021
Q4
$7K Sell
220
-150
-41% -$5.11K ﹤0.01% 2733
2021
Q3
$16K Buy
370
+120
+48% +$4.32K ﹤0.01% 2427
2021
Q2
$10K Sell
250
-1,850
-88% -$66.2K ﹤0.01% 6066
2021
Q1
$71.6K Buy
+2,100
New +$89.6K ﹤0.01% 1799

Other funds holding RGNX

Steward Partners Investment Advisory's RGNX Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Regenxbio (RGNX) stake by 79% in Q2 2026, selling an estimated $15.8K and leaving 513 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3895.

Steward Partners Investment Advisory first reported a position in RGNX in Q1 2021 and has held it in 22 quarters since. The position peaked at $326K in Q2 2024. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Steward Partners Investment Advisory held 513 shares of Regenxbio worth $6.15K as of Q2 2026.
  • Steward Partners Investment Advisory sold 1,900 Regenxbio shares in Q2 2026, an estimated $15.8K.
  • Regenxbio made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3895 holding.
  • Steward Partners Investment Advisory first reported a position in Regenxbio in Q1 2021 and has held it in 22 quarters since.
  • Steward Partners Investment Advisory's Regenxbio position peaked at $326K in Q2 2024.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.